Ken Griffin acquired 25.8 Thousand Neurocrine Biosciences shares worth $2.99 Million. That's 0.00% of their equity portfolio (1979th largest holding). The first Neurocrine Biosciences trade was made in Q2 2013. Since then Ken Griffin bought shares 63 more times and sold shares on 48 occasions. The stake costed the investor $2.25 Million, netting the investor a gain of 33% so far.